Earnings ·
Sanuwave reports Q3 revenue of $8.6M, down 24%, and GAAP operating loss of $1.1M
SNWVSANUWAVE Health, Inc.
Sanuwave Health reported third-quarter revenues of $8.6 million, a 24% decline from $11.3 million in the prior-year period, driven by a drop in Ultramist system sales to 40 units from 155. The company posted a GAAP operating loss of $1.1 million compared to an operating income of $0.9 million previously, while net loss widened to $1.4 million against a $9.7 million net gain last year that included non-recurring items. Adjusted EBITDA fell to $0.7 million from $3.2 million. The company cited CMS proposed rule changes and market uncertainty as key headwinds. Sanuwave Health develops regenerative medicine products for wound care.